CRYSVITA® SOLUTION FOR INJECTION 30 MG/ML
Product details
Registration number: SIN16177P
Classification: Prescription Only
Active ingredients: Burosumab
Strength: 30 mg/ml
Dosage form: INJECTION, SOLUTION
Route: SUBCUTANEOUS
Registrant: DKSH SINGAPORE PTE. LTD.
ATC code: M05BX05
HSA approval date: 30 April 2021
Manufacturer(s): KYOWA KIRIN CO., LTD., TAKASAKI PLANT
Manufacturing country/countries: JAPAN
What are the HSA registration number and classification for CRYSVITA® SOLUTION FOR INJECTION 30 MG/ML?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN16177P
Classification: Prescription Only
What active ingredients and strength are recorded for CRYSVITA® SOLUTION FOR INJECTION 30 MG/ML?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Burosumab
Strength: 30 mg/ml
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for CRYSVITA® SOLUTION FOR INJECTION 30 MG/ML?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, SOLUTION
Route: SUBCUTANEOUS
Who is the recorded registrant for CRYSVITA® SOLUTION FOR INJECTION 30 MG/ML?
According to the HSA dataset updated 7 August 2026:
Registrant: DKSH SINGAPORE PTE. LTD.
Which manufacturers and countries are listed for CRYSVITA® SOLUTION FOR INJECTION 30 MG/ML?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): KYOWA KIRIN CO., LTD., TAKASAKI PLANT
Manufacturing country/countries: JAPAN
Where can I look up CRYSVITA® SOLUTION FOR INJECTION 30 MG/ML in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN16177P or the exact product name CRYSVITA® SOLUTION FOR INJECTION 30 MG/ML. The general register link does not preselect this product.
What are the source dates for this CRYSVITA® SOLUTION FOR INJECTION 30 MG/ML record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this CRYSVITA® SOLUTION FOR INJECTION 30 MG/ML record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN16177P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)